← Back to Search

STAR - immediate for Neonatal Hearing Loss

N/A
Waitlist Available
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15-week intervention period
Awards & highlights
No Placebo-Only Group

Summary

This trial will establish preliminary feasibility and efficacy data for an literacy intervention for children with hearing loss, who are at risk for reading disorders.

Eligible Conditions
  • Neonatal Hearing Loss
  • Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15-week intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15-week intervention period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Phonological Awareness Literacy Screening-PreK (PALS-PreK)
Preschool Word and Print Awareness (PWPA)
STAR Fidelity Coding Checklist (FCC)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: STAR - immediateExperimental Treatment1 Intervention
Receive 15-week STAR intervention immediately after pretest.
Group II: STAR - waitlist controlActive Control1 Intervention
No intervention for the 15 weeks after pretest.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,127 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top